clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT01253174 |
P6099 | clinical trial phase | phase I clinical trial | Q5452194 |
P17 | country | Germany | Q183 |
P582 | end time | 2007-07-01 | |
P4135 | maximum age | 38 | |
P2899 | minimum age | 18 | |
P1132 | number of participants | 48 | |
P4844 | research intervention | calcium oxalate | Q412399 |
P580 | start time | 2006-08-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | Open-label, Randomized, Three-fold Crossover Study to Investigate the Bioequivalence of Two Different Tablet Formulations Containing 0.03 mg Ethinylestradiol (EE) and 3 mg Drospirenone (DRSP) Without [SH T470FA] and With [SH T04532A] 0.451 mg Metafolin®, and to Investigate the Bioequivalence of Two Different Tablet Formulations Containing 0.451 mg Metafolin® Without [SH T04532C] and With 0.03 mg EE/ 3 mg DRSP [SH T04532A] in 42 Healthy Young Women |